| Autor: |
Ken H. Young, L. Jeffrey Medeiros, Jane N. Winter, Miguel A. Piris, Michael B. Møller, John P. Farnen, Francesco Bertoni, Andrés J.M. Ferreri, Maurilio Ponzoni, Xiaoying Zhao, Jooryung Huh, J. Han van Krieken, William W.L. Choi, Eric D. Hsi, Kristy L. Richards, Govind Bhagat, Youli Zu, Attilio Orazi, April Chiu, Karen Dybkær, Santiago Montes-Moreno, Carlo Visco, Ling Li, Ganiraju C. Manyam, Alexandar Tzankov, Zijun Y. Xu-Monette, Jiayu Chen, Chi Young Ok |
| Rok vydání: |
2023 |
| Popis: |
Supplementary Figure 1. Morphology and immunophenotype of pSTAT3+ DLBCL. Supplementary Figure 2. Relationship between STAT3 mRNA and pSTAT3 expression and survival analysis based on STAT3 mRNA level. Supplementary Figure 3. Survival analyses based on pSTAT3 expression in DLBCL with MYC/BCL2 double expression and DLBCL without MYC/BCL2 double expression after COO stratification. Supplementary Figure 4. Overall survival (OS) and progression-free survival (PFS) in all DLBCL cases, DLBCL with germinal center B-cell-like phenotype (GCB) and DLBCL with activated B-cell-like phenotype (ABC). Supplementary Figure 5. Survival analyses in 3 and 4 groups based on pSTAT3 expression in lymphoma cells. Supplementary Table 1. Number of cases based on pSTAT3 expression, MYC/BCL2 double expression and COO classification Supplementary Table 2. The numbers and percentages of pSTAT3 positive DLBCL with each cutoff Supplementary Table 3. Clinical characteristics and cell-of-origin differentiation with 30% cutoff for pSTAT3 expression Supplementary Table 4. Distribution of cell-of-origin classification based on 4 groups of pSTAT3 expression in lymphoma cells. Supplementary Table 5. Distribution of cell-of-origin classification based on 3 groups of pSTAT3 expression in lymphoma cells. Supplementary Table 6. Bivariate analyses of pSTAT3 with each variable and pSTAT3. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
